Pathogenesis and motor neuron degeneration of a novel disease associated with a P158A mutation in NAMPT
与 NAMPT P158A 突变相关的新型疾病的发病机制和运动神经元变性
基本信息
- 批准号:10444087
- 负责人:
- 金额:$ 49.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-15 至 2027-01-01
- 项目状态:未结题
- 来源:
- 关键词:13 year oldAgingAnabolismAnimalsAtrophicAxonBiochemical ReactionBioenergeticsBiological AssayBiological ProcessBrainCell DeathCell divisionCellsCessation of lifeCitric Acid CycleClinicalCodeDNA RepairDataDendritic SpinesDevelopmentDiagnosisDiseaseDisease ProgressionElectron TransportElectrophysiology (science)Energy MetabolismEnzymesEssential GenesFibroblastsFoot DeformitiesFunctional disorderGene Expression ProfilingGenesGenetic DiseasesGlycolysisGoalsHand deformitiesHereditary Motor and Sensory NeuropathiesHumanImageIn VitroInborn Errors of MetabolismInheritedIschemic StrokeLeadLinkLower ExtremityMammalian CellMammalsMetabolicMetabolic PathwayMetabolic dysfunctionMetabolismMitochondriaMolecularMotorMotor CortexMotor NeuronsMusMuscleMuscle FibersMuscle WeaknessMutant Strains MiceMutationNerve DegenerationNeurogliaNeuromuscular JunctionNeuronsNeuropathyNiacinamideNicotinamide MononucleotideNicotinamide adenine dinucleotideOxidative PhosphorylationOxidative StressParalysedPathogenesisPathologicPathway interactionsPatientsPentosephosphate PathwayPhenotypePlayPreparationProductionProteinsRecombinantsReportingRespirationRoleSensorySiblingsSignal TransductionSingle Nucleotide PolymorphismSkinStable Isotope LabelingStressStructureSymptomsSynapsesTechnologyTestingTimeTissuesTransferaseVariantWestern BlottingWheelchairsWild Type Mouseaxonal degenerationbasecofactorfluorescence imaginggene functionhuman diseasein vivoinduced pluripotent stem cellmetabolomicsmitochondrial dysfunctionmotor impairmentmotor neuron degenerationmouse modelmuscle degenerationmutantmutant mouse modelnervous system disorderneuromuscular functionneuron lossnicotinamide phosphoribosyltransferasenovelpatch clampprotective effectresponsesynaptic functiontooltwo-photon
项目摘要
Project Summary
Nicotinamide adenine dinucleotide (NAD+) is a cofactor required for glycolysis, the tricarboxylic acid cycle (TCA)
and enzymatic reaction in electron transport chain (ETC). In mammalian cells, NAD+ salvage pathway, where
nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme, is the predominant pathway for
NAD+ biosynthesis. Although the dysregulation of NAD+ in aging and neurodegerative diseases has been
reported, genetic diseases caused by NAMPT variants have not been clinically recognized and understood. Here
we identified the first case of an inherited neurological disease caused by a homozygous single nucleotide
polymorphism (SNP), i.e., a P158A mutation in the coding region of NAMPT gene. The major clinical features of
patients include impaired motor coordination, muscle weakness, atrophy of lower extremities, positive Babiński
sign. The patients were diagnosed as hereditary motor and sensory neuropathy involving axonal degeneration
and neuromuscular junction (NMJ) dysfunction. Using skin-derived patient fibroblasts (p-FBs), our preliminary
studies found that P158A mutation causes reduced bioenergetics, mitochondrial dysfunction, and decreased
enzymatic activity of NAMPT for NAD+ biosynthesis compared with healthy control fibroblasts (c-FBs). The
results indicate the pathological conditions related to the patients is initially resulted from bioenergetic stress and
ultimately from neuronal and muscular degeneration. Thus, our project goal is to understand the pathogenesis
and the mechanism of neuronal and muscular degeneration of this new disease. To achieve our goal, we
generated many molecular tools including P158A-NAMPT mutant mice, c- & p-FBs-derived induced pluripotent
stem cells (c- & p-iPSCs including isogenic and patient like p-iPSCs), and iPSC-induced motor neurons (c- & p-
iMNs). We propose three Specific Aims. Aim 1 will test the hypothesis P158A mutation in NAMPT causes
mitochondrial and synaptic dysfunction of p-iMNs. Using iMNs, we will study the effect of P158A mutation
on cellular bioenergetics, glycolytic metabolism and mitochondrial respiration. We will also conduct combined
metabolomic and transcriptional profiling to determine the molecular base of metabolic changes caused by
P158A mutation. Aim 2 will test the hypothesis that P158A mutation in NAMPT causes MN degeneration.
Using the mutant mice, we will study disease progression, upper and lower MN degeneration. We will use
electrophysiological and two-photon (2-P) imaging to study the effect of P158A mutation on sensory response
and cytosolic and mitochondrial Ca2+ signaling. Aim 3 will test the hypothesis that P158A mutation in NAMPT
causes NMJ abnormalities and muscle degeneration. We will assess structural and functional abnormalities
of NMJs and muscle contractile response of semitendinosus muscles isolated from the symptomatic mutant
mice. A human disease caused by NAMPT mutation has not been reported so far. Our application represents a
first in-depth study on the pathogenesis and mechanism of motor neuron and muscle degeneration of a new
neurological disease caused by a mutation in NAMPT gene.
项目摘要
烟酰胺腺嘌呤二核苷酸(NAD+)是糖酵解、三羧酸循环(TCA)所需的辅因子
以及电子传递链(ETC)中的酶促反应。在哺乳动物细胞中,NAD+补救途径,其中
烟酰胺磷酸核糖基转移酶(NAMPT)是限速酶,是主要的途径,
NAD+生物合成。尽管NAD+在衰老和神经退行性疾病中的失调已经被证实,
据报道,由NAMPT变异体引起的遗传疾病尚未在临床上被认识和理解。这里
我们发现了第一例由纯合单核苷酸引起的遗传性神经疾病,
多态性(SNP),即,NAMPT基因编码区P158 A突变。主要临床特征
患者包括运动协调受损、肌无力、下肢萎缩、巴氏阳性
标志.患者被诊断为涉及轴突变性的遗传性运动和感觉神经病
和神经肌肉接头(NMJ)功能障碍。使用皮肤来源的患者成纤维细胞(p-FB),我们的初步
研究发现,P158 A突变导致生物能量学降低,线粒体功能障碍,
与健康对照成纤维细胞(c-FB)相比,NAMPT对NAD+生物合成的酶活性。的
结果表明,与患者相关的病理状况最初是由生物能量应激引起的,
最终导致神经元和肌肉退化因此,我们的项目目标是了解发病机制
并对这种新疾病的神经和肌肉变性机制进行了探讨。为了实现我们的目标,我们
产生了许多分子工具,包括P158 A-NAMPT突变小鼠,c-和p-FB衍生的诱导多能
干细胞(c-iPSC和p-iPSC,包括同基因的和患者样的p-iPSC)和iPSC诱导的运动神经元(c-iPSC和p-iPSC)。
iMN)。我们提出三个具体目标。目的1将检验P158 A突变导致NAMPT的假设,
p-iMN的线粒体和突触功能障碍。利用iMNs,我们将研究P158 A突变对
对细胞生物能量学、糖酵解代谢和线粒体呼吸的影响。我们还将联合
代谢组学和转录谱分析,以确定代谢变化引起的分子基础,
P158 A突变。目的2验证NAMPT中P158 A突变导致MN变性的假设。
使用突变小鼠,我们将研究疾病进展,上下MN变性。我们将使用
电生理和双光子(2-P)成像,以研究P158 A突变对感觉反应的影响
以及胞质和线粒体Ca 2+信号传导。目的3验证NAMPT中P158 A突变可能与NAMPT的发生有关的假设。
导致NMJ异常和肌肉退化。我们将评估结构和功能异常
从症状突变体中分离的NMJ和半腱肌的肌肉收缩反应
小鼠NAMPT突变引起的人类疾病至今未见报道。我们的应用程序代表了
首次深入研究了运动神经元和肌肉变性的发病机制和机制,
由NAMPT基因突变引起的神经系统疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shinghua Ding其他文献
Shinghua Ding的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shinghua Ding', 18)}}的其他基金
A novel therapeutic approach for Alzheimer Disease (AD)
阿尔茨海默病(AD)的新治疗方法
- 批准号:
10740016 - 财政年份:2023
- 资助金额:
$ 49.92万 - 项目类别:
Pathogenesis and motor neuron degeneration of a novel disease associated with a P158A mutation in NAMPT
与 NAMPT P158A 突变相关的新型疾病的发病机制和运动神经元变性
- 批准号:
10563210 - 财政年份:2022
- 资助金额:
$ 49.92万 - 项目类别:
THE ROLE AND MECHANISMS OF PBEF IN ACUTE BRAIN INJURY AND LONG-TERM STROKE OUTCOMES AFTER FOCAL ISCHEMIC STROKE
PBEF 在急性脑损伤和局灶性缺血性卒中后长期卒中结局中的作用和机制
- 批准号:
9535511 - 财政年份:2015
- 资助金额:
$ 49.92万 - 项目类别:
THE ROLE AND MECHANISMS OF PBEF IN ACUTE BRAIN INJURY AND LONG-TERM STROKE OUTCOMES AFTER FOCAL ISCHEMIC STROKE
PBEF 在急性脑损伤和局灶性缺血性卒中后长期卒中结局中的作用和机制
- 批准号:
9147010 - 财政年份:2015
- 资助金额:
$ 49.92万 - 项目类别:
The Role of Gliotransmission in Cerebral Ischemia
胶质细胞传输在脑缺血中的作用
- 批准号:
8641732 - 财政年份:2010
- 资助金额:
$ 49.92万 - 项目类别:
The Role of Gliotransmission in Cerebral Ischemia
胶质细胞传输在脑缺血中的作用
- 批准号:
8259199 - 财政年份:2010
- 资助金额:
$ 49.92万 - 项目类别:
Reactive astrocytes in neural regeneration and brain recovery after focal ischemic stroke
反应性星形胶质细胞在局灶性缺血性中风后神经再生和大脑恢复中的作用
- 批准号:
10458598 - 财政年份:2010
- 资助金额:
$ 49.92万 - 项目类别:
The Role of Gliotransmission in Cerebral Ischemia
胶质细胞传输在脑缺血中的作用
- 批准号:
8460525 - 财政年份:2010
- 资助金额:
$ 49.92万 - 项目类别:
Reactive astrocytes in neural regeneration and brain recovery after focal ischemic stroke
反应性星形胶质细胞在局灶性缺血性中风后神经再生和大脑恢复中的作用
- 批准号:
10220140 - 财政年份:2010
- 资助金额:
$ 49.92万 - 项目类别:
The Role of Gliotransmission in Cerebral Ischemia
胶质细胞传输在脑缺血中的作用
- 批准号:
8071506 - 财政年份:2010
- 资助金额:
$ 49.92万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 49.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 49.92万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 49.92万 - 项目类别:
Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 49.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 49.92万 - 项目类别:
Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 49.92万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 49.92万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 49.92万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 49.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 49.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




